BL-B16D1

DRUG3 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Breast CancerHead and Neck Squamous Cell CarcinomasSolid Tumor

Phase 1

A Study of BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

RecruitingNCT06469008

Sichuan Baili Pharmaceutical Co., Ltd.Head and Neck Squamous Cell Carcinomas, Solid Tumor

Start: 2024-06-27End: 2026-07-31Target: 21Updated: 2025-09-18

A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors

RecruitingNCT06475131

Sichuan Baili Pharmaceutical Co., Ltd.Solid Tumor

Start: 2024-07-18End: 2026-07-31Target: 21Updated: 2025-09-18

A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

RecruitingNCT06493864

Sichuan Baili Pharmaceutical Co., Ltd.Breast Cancer, Solid Tumor

Start: 2024-08-26End: 2026-07-31Target: 21Updated: 2025-09-18